NASDAQ · Biotechnology

HELP (HELP) Stock

$8.14 +2.91% NASDAQ: HELP Healthcare

Valuation

MetricValue
Price$8.14
Market Cap$504.55M
P/E Ratio-1.00
P/B Ratio82.65
P/S Ratio0.00
EPS (TTM)$-0.61
52-Week High$9.83
52-Week Low$3.76
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-55.89%
ROA-31.95%
ROCE-60.08%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.00
Current Ratio7.90

Annual Financials (USD)

Metric20212022202320242025
Revenue$1.0M$0$0$0$0
Operating Profit$-31.0M$-64.0M$-52.0M$-79.0M$-143.0M
Net Profit$-32.0M$-68.0M$-47.0M$-78.0M$-113.0M
EPS$-12.24$-15.36$-9.74$-9.41$-5.59
Op Margin-3592.0%————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$92.0M$84.0M$54.0M$302.0M$259.0M
Total Liabilities$6.0M$8.0M$6.0M$10.0M$21.0M
Cash$64.0M$54.0M$17.0M$209.0M$135.0M
Borrowings$0$0$0$0$0

Latest News

Psychedelic Therapy Meets M&A: Fireside Chat with Jupiter Neurosciences CEO Christer Rosén & President Alison Silva IPO-Edge.com · Jul 22, 2026 Helus Pharma Completes Enrollment in Phase 3 APPROACH Study of HLP003 in Adjunctive Treatment of Major Depressive Disorder Ahead of Schedule CNW Group · Jul 21, 2026 Cybin (HELP) Is Up 6.2% After Advancing HLP003 To Phase 3 And Raising US$50 Million Simply Wall St. · Jul 17, 2026 Johnson & Johnson’s Spravato sales growth supports psychedelic drug opportunity: Jefferies Proactive · Jul 15, 2026 Is Cybin D/B/A Helus Pharma (HELP) Stock a Psychedelic Medicine Opportunity Ahead of HLP003 Trial Results? Insider Monkey · Jul 15, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-19.0M$-45.0M$-47.0M$-69.0M$-101.0M
Investing Cash Flow$-1.0M$-1.0M$-7.0M$6.0M$-4.0M
Financing Cash Flow$6.0M$0$0$0$0
Net Cash Flow$62.0M$-10.0M$-37.0M$192.0M$-74.0M
Free Cash Flow$-19.0M$-46.0M$-51.0M$-70.0M$-103.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA-4.74
FCF Yield-105.30%
Quick Ratio13.78
Interest Coverage—
Return 1Y-0.39%
Return 3Y-49.65%
Return 5Y-93.72%

Ownership

Insiders Held2.75%
Institutions Held39.86%
Institutions Float Held40.98%
Institutional HolderSharesReport Date
Venrock Adviser, LLC3,851,6542026-03-31
Orbimed Advisors LLC.3,832,8432026-03-31
Millennium Management Llc2,415,8412026-03-31
Acorn Capital Advisors, LLC 1,540,2662026-03-31
Rosalind Advisors, Inc.1,531,8142026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About HELP

HELP is led by CEO Michael F. Cola, employs 50 people, headquartered in CA, publicly traded since 2019.

HELP stock trades at $8.14 with a market capitalization of $504.55M. The stock is valued at a price-to-earnings (P/E) ratio of -1.00, price-to-book of 82.65, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $3.76 and $9.83, and currently trades 17.2% below its 52-week high.

On profitability, HELP generates a return on equity (ROE) of -55.89%, return on capital employed of -60.08%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides